Fluorosalan
Fluorosalan is an NF-κB inhibitor. Fluorosalan blocks the NF-κB signaling pathway by inhibiting the phosphorylation of IκBα. Fluorosalan induces depolarization of mitochondrial membrane potential in cancer cells and inhibits the growth of various cancer cells. Fluorosalan can be used in studies related to cervical cancer and rheumatoid arthritis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 4776-06-1
- 分子式: C14H8Br2F3NO2
- 分子量:439.03
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| ME-180 | IC50 |
9.0 μM
|
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
|
20067776 |
| ME-180 | IC50 |
2.7 μM
|
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
|
20067776 |
| ME-180 | IC50 |
1.3 μM
|
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
|
20067776 |
| HeLa | IC50 |
3.1 μM
|
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
|
20067776 |
| HeLa | IC50 |
2.1 μM
|
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
|
20067776 |
| HeLa | IC50 |
3.3 μM
|
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
|
20067776 |
体外実験
Fluorosalan (30 min) inhibits TNF-α-induced phosphorylation of IκBα at serine-32 in GFP-IκBα GripTite HEK293 cells, with an IC50 of 2.8 μM[1].
Fluorosalan (10 μM; 1 h) reduces TNF-α-induced phosphorylation of IκBα at serine-32 in IkB HEK293 cells[1].
Fluorosalan (5-72 h) inhibits the viability of human cervical cancer HeLa cells, with IC50 values of 3.1 μM (24 h), 2.1 μM (48 h) and 3.3 μM (72 h)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:IkB HEK293 cells
-
Concentration:10 μM
-
Incubation Time:1 h
-
Result:Reduced TNF-α-induced IκBα phosphorylation at serine-32.
- Kinase activity and phosphorylation assays
- Western Blot
- Collagen-Induced Arthritis
- Mitochondrial membrane-potential fluorescent assay
- Fluorescent plasma-membrane potential dye assay
- Mitochondrial membrane-potential and mitochondrial mass staining
- Research Protocol for Inflammation-related Diseases
- Protocol for Kinase activity and phosphorylation assays
化学情報
-
CAS 番号 4776-06-1
-
分子量 439.03
-
分子式 C14H8Br2F3NO2
-
SMILES
O=C(NC1=CC=CC(=C1)C(F)(F)F)C=2C=C(Br)C=C(Br)C2O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)